Rotigotine (Neupro®) is a dopamine agonist used to treat Parkinson’s disease, available as a once-daily transdermal patch. By stimulating dopamine receptors, it helps reduce tremor, stiffness, and slowed movements, and can be used in both early and advanced stages of the disease. The patch provides steady drug delivery, which may help minimize motor fluctuations compared to oral dopamine agonists. Common side effects include skin irritation at the patch site, nausea, dizziness, sleepiness, and impulse-control problems. Rotigotine is especially useful for patients who prefer a non-oral option or have trouble with swallowing or pill compliance.